JNJ Related New Coverage

Nov 20, 2012 08:48 AM Stifel Nicolaus Starts Johnson & Johnson (JNJ) at Hold

Sep 11, 2012 08:16 AM Credit Suisse Reinstates Johnson & Johnson (JNJ) at Neutral

Mar 9, 2012 06:55 AM Jefferies Starts Johnson & Johnson (JNJ) at Hold

Dec 9, 2011 01:15 PM Barclays Initiating Coverage: A Seamless Approach to Biopharmaceuticals

Oct 21, 2011 08:16 AM Global Hunter Securities Starts Furiex Pharmaceuticals (FURX) at Buy; Diverse Pipeline Opens Multiple Opportunities

Oct 4, 2011 07:27 AM Cowen Starts Johnson & Johnson (JNJ) at Outperform

Sep 22, 2011 07:28 AM Kaufman Bros. Starts Boston Scientific (BSX) at Hold; Progress Made, But Remains a Turnaround, with Tough Growth Outlook

Sep 16, 2011 11:44 AM William Blair Initiates Research Coverage on MDVN, OGXI & DNDN: Three Companies in Prostate Cancer Treatment Space

Jul 8, 2011 07:00 AM Deutsche Bank Starts Johnson & Johnson (JNJ) at Hold; Some Upside But Mot Enough

Jun 17, 2011 08:16 AM Morgan Keegan Starts Coverage on 10 Healthcare Stocks: ABT, BSX, STJ at Outperform, JNJ, MDT at Market Perform

Jun 16, 2011 05:32 PM Brean Murray Carret & Co. Starts Johnson & Johnson (JNJ) at Buy, $77 Price Target

Jun 15, 2011 06:56 AM Brean Murray Carret & Co. Starts Johnson & Johnson (JNJ) at Buy

May 13, 2011 10:05 AM UPDATE - GARP Research Initiates Coverage on Conceptus (CPTS) with a Buy; Very Compelling Valuation

Apr 29, 2011 11:49 AM ThinkEquity Starts Dendreon (DNDN) at Buy, Sets $50 Price Target

Nov 10, 2010 11:47 AM CL King Starts Johnson & Johnson (JNJ) at Neutral

Jul 1, 2010 03:50 PM Standpoint Research Downgrades PG, JNJ, VZ to Hold; Starts CVX at Buy

Sep 30, 2009 11:42 AM Canaccord Adams Initiates Coverage on Palomar Medical Technologies (PMTI) with a Buy

Sep 30, 2009 09:34 AM Hapoalim Securities Initiates Coverage on Alkermes (ALKS) with a Hold; Two Uncertain Drivers

Aug 13, 2009 08:06 AM Goldman Sachs Resumes Coverage on Johnson & Johnson (JNJ) at Neutral

May 28, 2009 05:37 PM Piper Jaffray Initiates Coverage on Johnson & Johnson (JNJ) with a Neutral; Moderate Upside Potential for Steady Performer

Feb 26, 2009 08:00 AM RBC Capital Initiates Coverage on Several Medical Instruments & Supplies/Drug Stocks - Abbott Labs Named Top Pick

Nov 7, 2008 11:16 AM BofA Starts Johnson & Johnson (JNJ) at Neutral

Oct 23, 2008 10:46 AM Wasserman & Associates Initiates Coverage on Home Diagnostics (HDIX) with a Buy

Sep 5, 2008 08:40 AM Morgan Stanley Assumes Coverage on Johnson & Johnson (JNJ) with an Overweight

Jun 23, 2008 11:51 AM Leerink Swann Starts Johnson & Johnson (JNJ) at Market Perform

Apr 7, 2008 11:47 AM Boenning & Scattergood Starts Omrix Biopharm (OMRI) at Market Outperform

Jan 4, 2008 07:22 AM UBS Initiates Coverage on Johnson & Johnson (JNJ) with a Buy

Dec 17, 2007 02:36 PM Needham Starts NuVasive (NUVA) at Buy; Says Co Is An Attractive Buyout Target

Jul 10, 2007 06:03 PM Wachovia Securities Initiates Coverage on EYE, JNJ, BSX, BOL and COO with a Market Perform

Jan 10, 2007 08:37 AM Goldman Sachs resumes coverage on Johnson and Johnson (JNJ) with a Buy rating

Aug 7, 2006 07:48 AM Credit Suisse Starts Johnson & Johnson (JNJ) at Underperform

May 17, 2006 07:26 AM Goldman Sachs reinstated coverge on Johnson & Johnson (JNJ) at Outperform

Dec 9, 2005 07:54 AM Pruential Initiates Coverage on Medical Device Stocks

Oct 5, 2005 05:07 PM UBS Starts JNJ at Buy

Jul 20, 2005 08:58 AM JMP Securities Started JNJ at Market Perform

Apr 12, 2005 08:16 AM Needham Starts ARNA at Buy

Mar 29, 2005 07:02 AM Stanford Initiates Coverage On JNJ

Mar 28, 2005 04:38 PM Stanford Group Starts JNJ at Sell

Mar 7, 2005 07:10 AM JNJ started at Overweight at Lehman Brothers; $76 price tgt